Exercise With Liraglutide: Body-Fat and Bone Results From One Trial

When discussing body changes during GLP-1 treatment, ask what your exercise plan is intended to support: strength, fitness, body composition or another outcome. A Danish trial of liraglutide and structured exercise provides useful evidence, but its results belong to a particular protocol and population.

Body-fat percentage was a separate endpoint

Compared with liraglutide alone, the combination reduced body-fat percentage by an additional 1.9 percentage points (95% confidence interval, 0.5 to 3.3 points). The body-fat endpoint ran from randomization to one year. The Novo Nordisk Foundation and others funded the trial. [1]

Percentage points are not kilograms. A change from 40% to 38% body fat is a two-percentage-point change; it is not a statement that someone lost two kilograms of fat. Keep the measurement and time period together when comparing results with your own records.

The activity was organized and progressed

The protocol used a six-week ramp-up. From week seven, participants were encouraged to do two group sessions and two individual sessions weekly. Group sessions included 30 minutes of indoor cycling and 15 minutes of circuit work, including muscle-strengthening exercises. [2]

That is more specific than advice to “be active.” If a clinician recommends exercise alongside your treatment, ask what help is available with choosing activities, technique and progression. Do not copy the trial's diet phase or vigorous exercise schedule as a personal prescription.

The bone paper analyzed the same trial

A 2024 secondary analysis examined bone mineral density from before the diet phase to the end of treatment. Hip and spine results for the combination did not differ significantly from placebo. Liraglutide alone had lower hip and spine density than exercise alone. Follow-up bone measurements were available for 158 to 161 participants, depending on the site. [2]

The authors also described preserved lean mass in the combination group. These are body-composition and bone findings, not proof of fewer fractures or a particular cosmetic result. The bone paper is an additional analysis of the original participants, not an independent replication. [2]

Keep the medicine and population specified

The trial concerned liraglutide with an initial diet-induced weight loss and a year of treatment. Its results should not be presented as a measured effect for every GLP-1 medicine. The participants were adults with obesity without diabetes. [1]

For your appointment, name the medicine you take and your current activity level. Add any prior fracture, exercise limitation, dizziness or difficulty maintaining food intake. Ask the clinician which assessments and support fit your circumstances instead of using a study average as a personal target.

Translate the discussion into a workable week

For general adult health, CDC describes at least 150 minutes of moderate-intensity aerobic activity and two days of muscle-strengthening activity weekly. Activities can be divided across the week, and some movement is better than none. [3]

Ask how that general guidance should be adapted to your health and abilities. Write down the first activities, where you will do them, who can help with instruction and when the plan will be reviewed. Keep an exercise record separate from scale weight so progress is not judged only by weight change.

The trial did not test whether exercise prevents facial hollows or tightens loose skin after weight loss. For the broader consultation, read body shape, food and strength planning. If you are comparing a supplement claim, see the creatine trial review.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.